Navigation Links
Wayne State University researcher to study spinal muscular atrophy

DETROIT Graham Parker, Ph.D., assistant professor of research in the Department of Pediatrics at Wayne State University's School of Medicine, was awarded $418,000 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to study how a particular gene might be involved in the progression of spinal muscular atrophy (SMA) the number one genetic killer of children younger than 2 years old.

"Although most people have never heard of it, SMA is the most prevalent hereditary motor neuron disease, affecting four to 10 per 100,000 live births, with as many as one in 75 people being carriers of the genetic mutation," said Parker.

There is no cure for or treatment to slow the progression of SMA, but Parker and co-investigator Gyula Acsadi, M.D., Ph.D., associate professor of pediatrics and neurology, hope to clarify the role of alpha-synuclein (SNCA), which they believe is a potentially significant genetic biomarker of the neuromuscular disease. A better understanding of SNCA's role may help develop new therapies to treat SMA.

Spinal muscular atrophy is characterized by diseased motor neurons in the spinal cord. Typically, these motor neurons send signals to various muscles throughout the body, like those that control breathing. But in the diseased state, the neurons degenerate and die, resulting in muscle weakness of varied severity.

So, what causes the motor neurons to become diseased in the first place? "The genetic cause of SMA is well established: the lowering of survival motor neuron (SMN) protein, which exists in all cells," said Parker. "But we still have no idea why SMN loss specifically affects the motor neurons in this way."

Evidence from their previous research, however, points toward SNCA.

"Our analyses of SMN-deficient neuronal cells discovered that low levels of SMN are associated with reduced SNCA gene expression," he said. "Recent work has indicated that downregulation of SNCA can compromise the viability of neural cells."

In this study, Parker will put SNCA to the test. He aims to determine whether dramatically decreasing SNCA expression levels will mimic the motor neuron death observed under SMA conditions. He will then increase SNCA expression levels to see if this slows the progression of SMA.

Parker expects his findings to come with important implications for the discovery of new therapies. "The knowledge gained from this research is a highly desirable goal, potentially allowing us to identify more useful disease markers for future clinical trials, as well as develop new models to advance neuromuscular disease research," said Parker.


Contact: Julie O'Connor
Wayne State University - Office of the Vice President for Research

Related medicine news :

1. Wayne State University awarded $3 million from NIH to foster science and research careers
2. Wayne State researcher receives NSF award to develop neural implants
3. Wayne State University engineering student receives American Tinnitus Association award
4. Wayne State University researcher argues that sex reduces genetic variation
5. Health providers should emphasize breast cancer screening, Wayne State University research finds
6. Religion benefits traumatic brain injury victims, Wayne State University research finds
7. Wayne State University researchers win grant from the NSF to target tinnitus
8. Wayne State researchers find new way to examine major depressive disorder in children
9. Wayne State leads study to improve management of cancer pain in African Americans
10. Wayne State study links testosterone with mens ability to woo potential mates
11. Wayne State University researchers publish results settling multiple sclerosis debate
Post Your Comments:
(Date:11/30/2015)... ... , ... The Foundation for Breast and Prostate Health (FBPH)—a ... with the award-winning creator and writer of Downton Abbey Julian Fellowes to host ... Union League of Philadelphia. , The benefit, titled “An Evening with Julian ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties products ... markets in the US, effective immediately. , “We are pleased to announce ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i Systems, a ... today that Michigan-based Family Health Center (FHC) has selected i2iTracks as their population ... was awarded the largest Affordable Care Act grant for Federally Qualified Health Centers ...
(Date:11/30/2015)... PITTSBURGH, PA (PRWEB) , ... November 30, 2015 , ... ... quality of life in the womb. "My last baby had high blood pressure due ... way for mothers to protect their babies from noise pollution as well as radio ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an interview with Andy ... a top ophthalmologist on Long Island’s east end. During the broadcast, entitled “Eyes: the ... and treatment of glaucoma and cataracts, and how a visit with his grandmother to ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... KIRKLAND, Wash. , Nov. 30, 2015 /PRNewswire/ ... of Post-Processing services, is pleased to announce a ... of medical imaging services. Building on its ISO-9001:2008 ... adopted and implemented comprehensive Core Lab protocols and ... wide variety of research activities.  Their Core Lab ...
(Date:11/30/2015)... 30, 2015 Mexico Healthcare and Life Sciences ... Report 2015 . --> Pharmaboardroom releases its new 98-page ... Latin America , a country of over 122 million ... of over 122 million people. --> It offers companies, ... life sciences insights into the second largest pharma and healthcare market ...
(Date:11/30/2015)... , November 30, 2015 Elbit ... the "Company") announced today that it was informed by InSightec ... Drug Safety (MFDS) has approved its Exablate Neuro system ... --> --> Insightec,s Exablate Neuro ... alternative that combines two technologies: Focused Ultrasound, which is ...
Breaking Medicine Technology: